ADC Therapeutics SA SEC filings ADCT
ADC Therapeutics SA has 438 filings in SEC EDGAR's recent list, going back to Jun 27, 2019. Its latest annual report, Form ARS, was filed on Mar 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 20, 2026 | — |
| DEF 14A | Proxy statement | Apr 20, 2026 | Jun 1, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 10, 2026 | Jun 1, 2026 |
| DEF 14A | Proxy statement | Apr 21, 2025 | Jun 3, 2025 |
| DEFA14A | Additional proxy material | Apr 21, 2025 | — |
| PRE 14A | Preliminary proxy statement | Apr 9, 2025 | Jun 3, 2025 |
| DEFA14A | Additional proxy material | Sep 23, 2024 | — |
| DEF 14A | Proxy statement | Sep 23, 2024 | Nov 11, 2024 |
| PRE 14A | Preliminary proxy statement | Sep 13, 2024 | Nov 11, 2024 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 13, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2024 | Jun 13, 2024 |
Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ADCT (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- Switzerland
- Headquarters
- Epalinges, Switzerland
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1771910
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.